Among the PD patients, serum IGF-1 levels were lower in the anxiety subgroup, depression subgroup, and cognitive dysfunction subgroup than in the subgroups without anxiety (143.66 ± 35.47 mmol/L vs. This evidence concerns the gene IGF1 and Parkinson disease.